SEREN PHARMACEUTICALS
Selenium Pharma Co., Ltd. is a clinical development-specific pharmaceutical company that introduces development candidates that have been confirmed by POC (Proof of Concept) from pharmaceutical companies, etc., and efficiently develops them quickly with a small group of specialists.
SEREN PHARMACEUTICALS
Industry:
Biotechnology
Founded:
2010-04-30
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.serenpharma.com
Total Employee:
1+
Status:
Active
Contact:
03-5244-9343
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Analytics Apache Google Analytics Classic GlobalSign GMO Internet DNS GMO Internet
Official Site Inspections
http://www.serenpharma.com
- Host name: www5.gmoserver.jp
- IP address: 157.7.231.240
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "Seren Pharmaceuticals"
About US | Seren Pharmaceuticals Inc.
[email protected] Board Members. President&CEO Akira Nakagawa; CEO Daisaku Shimoda; Executive VP Masakazu Fukusakura; Director Takahiro Aihara; Auditor Eiji Mizuta; …See details»
Seren Pharmaceuticals Inc.
Clinical Development-Focused Business Model. SEREN Pharmaceuticals Inc. is a private pharmaceutical company focusing on clinical development, aims at early commercialization by in-licensing development candidates from …See details»
株式会社セレンファーマ
Clinical Development-Focused Business Model. 株式会社セレンファーマは POC（Proof of Concept）が確認されている開発候補品を製薬会社等から導入、少数の専門家集団により効率的に開発し、早期に製品化する臨床開発特化型 …See details»
Seren Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 03-5244-9343 Selenium Pharma Co., Ltd. is a clinical development-specific pharmaceutical company that introduces development …See details»
SEREN PHARMACEUTICALS - Overview, News & Similar companies …
SEREN PHARMACEUTICALS contact info: Phone number: +81 352449343 Website: www.serenpharma.com What does SEREN PHARMACEUTICALS do? Seren …See details»
SEREN PHARMACEUTICALS INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SEREN PHARMACEUTICALS INC. of CHUO-KU, TOKYO. Get the latest business insights from Dun …See details»
Seren Pharmaceuticals, Inc. - Massachusetts Institute of Technology
Jul 3, 2023 Discovery Company profile page for Seren Pharmaceuticals, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Seren Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Sep 13, 2024 Explore Seren Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
KTZ-S 2%の頭部脂漏性皮膚炎に対する第Ⅲ相試験 －ランダム …
Sep 1, 2024 組織名 / Organization: 株式会社セレンファーマ: 部署名 / Division: Seren Pharmaceuticals Inc. 住所 / Address: 東京都中央区日本橋人形町一丁目2番13号: 1-2-13, …See details»
会社概要｜株式会社セレンファーマ - serenpharma.com
会社案内 会社名 株式会社セレンファーマ 設立 2010年4月30日（事業改編） 所在地 〒103-0013 東京都中央区日本橋人形町1-2-13 日本橋doll-1ビル3階・4階（受付3階）See details»
Seren Pharmaceuticals, Inc. (Seren Pharmaceuticals, Inc.) - 药物管 …
了解Seren Pharmaceuticals, Inc. (Seren Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1篇文献。See details»
SATO PHARMACEUTICAL AND EISAI TO CO-PROMOTE NEW ORAL …
Oct 3, 2017 Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as “giving first thought to …See details»
株式会社セレンファーマの会社情報と与信管理 | NIKKEI …
Sep 7, 2023 東京都中央区日本橋人形町1丁目2番13号 過去6期分の売上高、税引後利益、資本構成などの財務項目を収録 佐藤製薬 有価証券報告書－第83期(令和3 ...See details»
ホスラブコナゾールを有効成分とする新規経口抗真菌剤 佐藤製薬 …
Oct 3, 2017 ホスラブコナゾールは、エーザイが創製した新規の経口抗真菌剤です。ホスラブコナゾールは、主活性成分であるラブコナゾールの溶解性や生体内利用率を向上させたプロド …See details»
経営戦略 | Seren Pharmaceuticals Inc.
Management Strategy 1. Search of Potential Dormant Products. We discover dormant products that have been confirmed as POC (Proof of Concept) in humans by pharmaceutical …See details»
Serentrix Company Profile - Office Locations, Competitors, …
Serentrix is a company that provides targeted small molecule therapy for innocuous pain relief. It develops a clinical pipeline of therapies that address pain associated with dry eye, irritable …See details»
Acerus Announces Closing of Acquisition of Serenity
Mar 7, 2022 Acerus Announces Closing of Acquisition of Serenity Pharmaceuticals LLC and Acquisition of Global Rights to Noctiva™See details»
経営戦略｜株式会社セレンファーマ - serenpharma.com
経営戦略 1. Search of Potential Dormant Products. 製薬会社等において、ヒトでのPOC (Proof of Concept)が確認されているが、開発優先順位が低く、開発が進まない休眠製品（成功確率の …See details»
Kern Pharma
Kern Pharma is a multinational dedicated to the pharmaceutical industry and a leader in generics production.It develops, makes and markets its own pharmaceutics and is a trusted third-party …See details»
Development Pipeline | Seren Pharmaceuticals Inc.
Development Pipeline. Copyright© Seren Pharmaceuticals Inc. All Rights Reserved. pagetopSee details»